Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combination.

Vasc Health Risk Manag · 2008 · PMC2515425 · PMID 18827915

Europe PMC DOI

hedged sentence

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

a trend toward significancep = 0.087so close (0.05 < p ≤ 0.1)

The reduction in mean 24-hour DBP with olmesartan (8.5 mmHg) was significantly greater than reductions with losartan and valsartan (6.2 and 5.6 mmHg, respectively, p < 0.05) and showed a trend toward significance compared with the reduction in DBP with irbesartan (7.4 mmHg; p = 0.087).

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.